Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1984 Nov;83(3):687-95.
doi: 10.1111/j.1476-5381.1984.tb16222.x.

Solubilization of dopamine-D2 receptors from synaptosomal membranes of the bovine caudate nucleus

Solubilization of dopamine-D2 receptors from synaptosomal membranes of the bovine caudate nucleus

M Kidric et al. Br J Pharmacol. 1984 Nov.

Abstract

Dopamine D2-receptors were solubilized from synaptosomal membranes of the bovine caudate nucleus using different detergents. They were labelled with [3H]-spiperone and assayed by polyethylene glycol precipitation. CHAPS was found to be the best solubilizing agent among all detergents used. Optimal conditions for solubilization were: 0.25% CHAPS, 3.5 mg ml-1 protein, 25 min, 4 degrees C and the yield of D2-receptors was 18.6%. Addition of some sulphobetain detergents increased the extent of solubilization, 125 mM NaCl and 0.25 M sucrose decreased it, while SH-group protecting agents (2 mM dithiothreitol and 6 mM beta-mercaptoethanol), as well as MEGA-9 and MEGA-12 were almost ineffective. -log IC50 values for solubilized dopamine D2-receptors are in linear correlation with the corresponding values for membrane-bound receptors (r = 0.962, slope factor 0.96) and Kd value of solubilized receptors was 3.61 +/- 0.94 nM, while that of membrane-bound receptors was 1.25 +/- 0.10 nM. Specific binding of [3H]-spiperone to the solubilized receptors resolved by linear sucrose density gradient centrifugation shows two maxima, one in the first several fractions from the bottom and the other with an apparent S value of 7.3.

PubMed Disclaimer

References

    1. Eur J Pharmacol. 1981 Aug 27;74(1):53-9 - PubMed
    1. Life Sci. 1981 Jul 27;29(4):313-30 - PubMed
    1. Prog Neuropsychopharmacol. 1981;5(5-6):543-8 - PubMed
    1. Eur J Pharmacol. 1982 Mar 26;78(4):431-8 - PubMed
    1. Life Sci. 1982 Apr 26;30(17):1407-22 - PubMed

Publication types

LinkOut - more resources